Gentle care for itchy dogs, Virbac’s Allerderm Spot-On focuses on the skin barrier

Reviewed: ad hoc news Accessory & Components desk. Edited and checked on 2026-06-17, 22:07. Details in the imprint.

With Allerderm Spot-On, Virbac puts a tiny plastic pipette into the hand of dog owners that can feel like a small relief ritual on itchy evenings. The clear liquid spreads along the fur line, vanishes into the coat, and quietly targets the stressed skin barrier.

What Allerderm is built for

Allerderm Spot-On is a topical skin care product for dogs and cats, developed for animals with sensitive, allergic, or irritated skin. It is used alongside veterinary therapy, not as a stand-alone drug, and aims to support the skin’s physical barrier.

The formula is based on so-called essential epidermal lipids, mainly ceramides, cholesterol, and free fatty acids that mirror the components of the natural skin barrier according to Virbac’s dermatology portfolio description. The manufacturer positions it as a complement in atopic dermatitis cases and chronic pruritus.

How the pipettes are used

Each Allerderm Spot-On pipette is meant to be applied directly onto the skin, typically along the back line where the animal cannot lick easily. Pet owners twist off the tip, part the hair, and squeeze the contents onto several spots so the fluid can spread.

Virbac recommends a loading phase with more frequent application followed by a maintenance schedule, depending on the veterinarian’s plan and the severity of the skin condition. In daily life that means a few calm minutes on the sofa, a towel under the pet, and a short massage into the fur.

What is inside the formula

The core of Allerderm Spot-On is the so-called S-I-S or skin-innovative system, a mixture of skin-identical lipids designed to restore the protective hydrolipid film. This concept mirrors the company’s broader dermatology range, where epidermal lipid complexes are a recurring motif across shampoos and lotions.

The liquid is non-greasy and designed to spread quickly, which matters for animals that dislike long grooming routines. Pet owners report that, once applied correctly, the product usually leaves only a slight sheen on the coat that disappears as the lipids absorb into the skin.

Place in allergy management

Veterinarians typically embed Allerderm Spot-On into multi-layered allergy and itch management plans combining diet, antiparasitic treatment, systemic drugs, and topical care. Used this way, the pipettes are one brick in a longer therapy wall rather than a quick cure.

In chronic atopic dogs, maintaining the skin barrier can help reduce flare-ups and secondary infections over time, which is why Virbac keeps a strong focus on barrier repair in its communication on dermatological ranges. Owners, however, still need patience, as visible improvements can take several weeks.

Strengths and limits in practice

Allerderm Spot-On plays its strengths when owners are willing to keep a routine: regular application, gentle handling, and coordination with veterinary checks. The format fits easily into a drawer, travels well, and does not require bathing or rinsing.

Its limits become obvious when expectations are unrealistic. On severely inflamed, infected, or bleeding skin, a lipid complex alone will not replace prescription drugs or medicated shampoos. The product is supportive care, not a miracle fix for advanced disease.

Where and for whom it makes sense

The pipettes target dogs and cats that show recurring itching, dry skin, or a history of environmental allergies diagnosed by a vet. For short-coated breeds, application is straightforward; on long-haired animals owners may need more time to reach the skin evenly.

In Europe, Virbac distributes Allerderm Spot-On mainly through veterinary clinics and pet pharmacies rather than grocery retail. That underlines the semi-medical positioning of the product, which sits between simple grooming cosmetics and prescription dermatology drugs.

Company context and stock note

Dermatology and allergy support have long been pillars in Virbac’s companion animal portfolio, reinforcing the brand’s image as a specialist rather than a generic feed player. Allerderm Spot-On fits neatly into that story as a quiet accessory that underpins long-term therapies.

Shares of Virbac (FR0000031577) are listed on Euronext Paris in euros.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.